Results 31 to 40 of about 2,643,317 (205)

Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature [PDF]

open access: yesBrazilian Journal of Medical and Biological Research, 2015
We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients.
L. Wang, F. Du, H.-M. Zhang, H.-X. Wang
doaj   +3 more sources

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia [PDF]

open access: yesJournal of Hematology & Oncology, 2014
According to the 2008 World Health Organization classification, chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia are rare diseases. The remarkable progress in our understanding of the molecular genetics of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms has made it clear ...
Li, Bing   +2 more
openaire   +2 more sources

Atypical Chronic Myeloid Leukemia

open access: yesBlood, 2018
Abstract Introduction: Atypical chronic myeloid leukemia (aCML), BCR-ABL1 negative is a rare myelodysplastic syndromes (MDS)/myeloproliferative neoplasm (MPN) for which no current standard of care exists. We present one of the rare presentations of aCML in an elderly patient.
Chandralekha Ashangari   +1 more
openaire   +1 more source

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia [PDF]

open access: yesNature Genetics, 2012
Atypical chronic myeloid leukemia (aCML) shares clinical and laboratory features with CML, but it lacks the BCR-ABL1 fusion. We performed exome sequencing of eight aCMLs and identified somatic alterations of SETBP1 (encoding a p.Gly870Ser alteration) in two cases.
PIAZZA, ROCCO GIOVANNI   +27 more
openaire   +4 more sources

Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia [PDF]

open access: yesCancer, 2020
ABSTRACT There is limited data on the clonal mechanisms underlying leukemogenesis, prognostic factors, and optimal therapy for atypical chronic myeloid leukemia (aCML). We evaluated the clinicopathological features, outcomes, and responses to therapy of 65 patients with aCML. Median age was 67 years (range 46-89). The
Guillermo Montalban‐Bravo   +24 more
openaire   +2 more sources

A dual origin for Bcr-Abl gene translocation/fusion as dynamics of synergism of the hematopoietic stem cell and hemangioblast in chronic myeloid leukemia [PDF]

open access: yes, 2015
Contextual BCR-ABL tyrosine kinase over-activity determines in formulated fashion the emergence of proliferation and anti-apoptosis that arise largely as derived phenomena of otherwise homeostatic mechanisms of the c-ABL gene within hematopoietic ...
Agius, Lawrence M.
core   +1 more source

Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters [PDF]

open access: yes, 2009
Imatinib mesylate and nilotinib are highly effective at eradicating the majority of chronic myeloid leukemia (CML) cells; however, neither agent induces apoptosis of primitive CML CD34<sup>+</sup> cells.
Holyoake, T.L.   +10 more
core   +2 more sources

Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: Novel Pathogenetic Lesions [PDF]

open access: yesSeminars in Oncology, 2012
Chronic myelomonocytic leukemia (CMML) and atypical chronic myeloid leukemia (aCML) are distinct, yet related, entities of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) characterized by morphologic dysplasia with accumulation of monocytes or neutrophils, respectively.
Hideki, Muramatsu   +2 more
openaire   +2 more sources

Chronic myeloid leukemia stem cells display alterations in expression of genes involved in oxidative phosphorylation [PDF]

open access: yes, 2012
The mitochondrial respiratory chain (MRC) consists of protein complexes I, II, III, IV and V that support oxidative phosphorylation (OXPHOS), which depends on electron transport to generate adenosine triphosphate (ATP).
Flis, Krzysztof   +9 more
core   +1 more source

Treatment-free remission in Chronic Myeloid Leukemia harboring atypical BCR-ABL1 transcripts.

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2020
Discontinuation of tyrosine kinase inhibitors (TKI) is the main goal today in the field of Philadelphia positive chronic myeloid leukemia (Ph + CML) and the criteria to attempt the interruption of therapy are well defined and rely on the possibility to ...
Matteo Dragani   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy